0% found this document useful (0 votes)
59 views40 pages

Time Is Muscle - Understanding Heart Attack

Uploaded by

tricia isabella
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
59 views40 pages

Time Is Muscle - Understanding Heart Attack

Uploaded by

tricia isabella
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 40

Time is Muscle: Understanding Heart Attack

Hendri Susilo, dr., Sp.JP.


Universitas Airlangga Teaching Hospital

1
▪ Chest pain accounts for ± 7.6 million annual visits to ER in the US
▪ Making chest pain the 2nd most common complaint.

▪ Patients present with a spectrum of signs and symptoms reflecting the many
potential etiologies of chest pain.
▪ Diseases of the heart, aorta, lungs, esophagus, stomach, mediastinum, pleura,
and abdominal viscera may all cause chest discomfort.
▪ Clinicians in the ED focus on the immediate recognition and exclusion of life-
threatening causes of chest pain.
▪ Patients with life-threatening etiologies for chest pain may appear deceptively
well, manifesting neither vital sign nor physical examination abnormalities.

https://www.cdc.gov/nchs/data/nhamcs/web_tables/2017_ed_web_tables-508.pdf. 2
CASE ILUSTRATION
▪ A 60 years old man, heavy smoker, came to the ER with
6 hours onset of typical chest pain (VAS 7/10)
▪ Vital sign
▪ BP 119/71 mmHg, HR 80 bpm, RR 20, axillar temp 370C, SpO2
98%

▪ Physical exam within normal limits

3
✓Onset of pain (eg, abrupt or gradual)
✓Provocation (which activities provoke pain; which alleviate pain)
✓Quality of pain (eg, sharp, squeezing, pleuritic)
✓Radiation (eg, shoulder, jaw, back)
✓Site of pain (eg, substernal, chest wall, back, diffuse, localized)
✓Timing (eg, constant or episodic, duration of episodes, when pain began)

Risk factors: male sex, age over 55 years, family history of CAD, DM,
hypercholesterolemia, hypertension, and tobacco use.
<10 minutes of patient
presentation inthe ED
Patients with normal or nonspecific ECGs have a 1-5% incidence of AMI and a 4-23%
incidence of UA. The ECG can be repeated if the initial ECG is not diagnostic but the
patient remains symptomatic and there remains high clinical suspicion for AMI.

5
6
RV infarction is diagnosed based on the following findings:
•There is an inferior STEMI with ST elevation in lead III > lead II
•V1 is isoelectric while V2 is significantly depressed
•There is ST elevation throughout the right-sided leads V3R-V6R

7
QUESTION?...
1. We have to confirm the diagnosis with serum marker to
establish the diagnosis… (T/F)
2. At the moment your diagnosis is?
a. Unstable Angina
b. Non STEMI
c. STEMI

8
10 minutes

No need to
wait the result

Eur Heart J, Volume 42, Issue 14, 7 April 2021, Pages 1289–1367, https://doi.org/10.1093/eurheartj/ehaa575
9
The content of this slide may be subject to copyright: please see the slide notes for details.
▪ DUAL ANTIPLATELETS: Aspirin 300-325 mg plus ?
▪ Prasugrel 60 mg loading, then 10 mg od
▪ Ticagrelor 180 mg loading, then 90 bid mg
▪ Clopidogrel 600 mg loading then 75 mg od

▪ NITRATE (avoid in RV infarct)


▪ BETA-BLOCKER (if not contraindicated)
▪ STATIN
▪ THROMBOLYTIC vs PPCI (gold standard)

10
DIAGNOSTIC CORONARY ANGIOGRAPHY

11
12
13
14
PRIMARY PCI PROSEDURE

15
16
• Hipotensi
• NE mulai 50 nano

• Brdikardi
• SA 1 mg

17
18
19
PRE POST

20
VT pulse konvesi spontan menjadi sinus takikardi

21
ACUTE CORONARY SYNDROME

ST Elevation Non ST Elevation

SIMILAR INITIAL TREATMENT

URGENT REPERFUSION RISK STRATIFICATION

Invasively Medically
Primary PCI Fibrinolysis
managed managed
22
Pathophysiology of Acute Coronary Syndromes

23
PATHOGENESIS Biomarker Release

24
Characteristics of Chest Pain in Myocardial Ischemia

25
• Angina occurring at rest and usually prolonged
Rest angina >20 min occurring within a week of presentation

New-onset • Angina of at least CCSC III severity with onset


angina within 2 months of initial presentation

Increasing • Previously diagnosed angina that is distinctly more frequent,


longer in duration or lower in threshold (i.e., increased by at

angina least one CCSC class within 2 months of initial presentation


to at least CCSC III severity)

26
Principal causes of chest pain

27
DIAGNOSIS
Target:
ECG ≤10 minutes from
First Medical Contact

- ST-Elevation in minimal
two contagious lead
J-point + 0,04 Sec
≥0,1mV

- In lead V2-V3 :
Baseline ≥0,2 mV in male ≥40 y.o
≥0,25 mV in male<40 y.o
≥0,15 mV in female

ESC Guidelines, 2012


MANAGEMENT

Early diagnosis

Reperfusion therapy ASAP

Optimal secondary prevention

29
EMERGENCY ROOM
OXYGENATION

Indicated in patient with hypoxia (Sa02 <90%), dyspnea, and heart failure

INTRAVENOUS OPIOID
• Morphine 4-8 mg i.v
• Relieve pain and anxiety
• Adverse reaction: Hypotension, respiratory depression, and vomiting

ASPIRIN
• Aspirin oral (chewable) or i.v should be given in STEMI
• Loading dose 300-325 mg , maintenance dose 75-100 mg od
31
EMERGENCY ROOM
P2Y12 RECEPTOR BLOCKER
• Ticagrelor & Prasugrel are preferable and recommended in patients
who planned for Primary PCI
• Loading dose Ticagrelor 180 mg or Prasugrel 60 mg
• Loading dose Clopidogrel 600 mg (Primary PCI) or 300 mg (Fibrinolysis)
NITRATE
• Short acting nitrates (Nitroglyserin 0,4 mg or ISDN 5 mg S.L) is recommended
• Should not be given in : RV infarction is suspected, hypotension, still in effect of
sildenafil/viagra, aorta stenosis, & HOCM
BETA BLOCKERS
• Reduce myocardial oxygen demand and incident of lethal arrhythmia
• Should not be given in: acute heart failure (Killip >2), significant AV Block,
hypotension (SBP<90mmHg) and bradycardia (<60bpm)
33
REPERFUSION THERAPY STRATEGY
Primary PCI Fibrinolysis

VS
Eur Heart J, Volume 39, Issue 2, 07 January 2018, Pages 119–177, https://doi.org/10.1093/eurheartj/ehx393
The content of this slide may be subject to copyright: please see the slide notes for details.
Eur Heart J, Volume 39, Issue 2, 07 January 2018, Pages 119–177, https://doi.org/10.1093/eurheartj/ehx393
The content of this slide may be subject to copyright: please see the slide notes for details.
37
38
• Acute emergency care is very important, the key point of STEMI
management is reperfusion therapy
• Determining the appropriate reperfusion therapy strategy is highly
depend on the clinical setting and resource availability in each
medical center
• Time to perform reperfusion is the most important variable to get
a better outcomes

39
40

You might also like